CHANGHONG JH(03991): Lin Qianxi has been appointed as the company secretary, authorized representative, and agent for legal documents.

18:17 12/08/2026

Changhong Jiahua (03991) announced that Mr. Zheng Chengjie has submitted his resignation, effective from August 12, 2026, as (i) the company secretary of the company, (ii) the authorized representative of the company under Rule 3.05 of the Securities Listing Rules of The Stock Exchange of Hong Kong Limited, and (iii) the authorized representative of the company for receiving legal documents and notices in Hong Kong as stipulated in Part 16 of the Companies Ordinance (Cap. 622) of the Hong Kong legislation.

CHANGHONG JH (03991) announced that Mr. Zheng Chengjie has submitted his resignation, resigning from (i) the position of company secretary of the company, (ii) the authorized representative of the company under Rule 3.05 of the Listing Rules of The Stock Exchange of Hong Kong Limited, and (iii) the authorized representative to receive legal documents and notices on behalf of the company in Hong Kong under Section 16 of the Companies Ordinance (Cap. 622) of Hong Kong, effective from August 12, 2026. Following Mr. Zheng's resignation, Ms. Lin Qianxi has been appointed as the company secretary, authorized representative, and agent for receiving legal documents on behalf of the company, effective from August 12, 2026.

MODERN DENTAL (03600) has cancelled 636,000 repurchased shares.

ORIENTAL EXPL (00430) issues a profit warning, expecting that integrated profit attributable to shareholders for the first half of the year will decrease to approximately HK$3 million to HK$3.2 million.

Jiangsu Hengrui Pharmaceuticals (01276): SHR-7590 injection has obtained the Drug Clinical Trial Approval Notification.

MODERN DENTAL (03600) has cancelled 636,000 repurchased shares.

Jiangsu Hengrui Pharmaceuticals (01276): SHR-7590 injection has obtained the Drug Clinical Trial Approval Notification.